HIV Testing WHO Launches Guideline Development Group to Establish New HIV Prevention and Testing Standards for Lenacapavir The World Health Organization (WHO) has announced the formation of a new Guideline…
Biopharma Leaders M&A Didn’t Deliver as Expected in 2024: Biopharma Turns to JPMorgan Healthcare Conference for Optimism Biopharma Leaders the much-anticipated mergers and acquisitions (M&A) wave that the biopharma industry…
Astellas Pharma recently announced the approval Gastric Cancer of VYLOYTM (zolbetuximab) by China’s National Medical Products Administration (NMPA) for first-line treatment of locally advanced unresectable or metastatic human epidermal growth…
Revolution Medicines, a clinical-stage oncology company focused on developing targeted therapies for patients with RAS-addicted cancers, recently announced the successful closing of its upsized underwritten public offering. The offering comprised…
Heart Disease: The Importance of Regular Health Screenings Care Access, a leading health Heart Disease and research company, is bringing its Heart & Kidney Health Screening initiative to Pearland, Texas.…
Cytokinetics, Incorporated has announced the granting of equity awards as material inducements to new employees under Nasdaq Listing Rule 5635(c)(4). These grants, made on December 31, 2024, include stock options,…
Amid the growing global shortage of Pegasys® (peginterferon alfa-2a), PharmaEssentia (TWSE: 6446), a global biopharmaceutical company, is reaffirming its steadfast commitment to ensuring robust and reliable access to critical interferon…
The oncology pharmaceuticals market, valued at $196.4 billion in 2023, is expected to grow at a robust compound annual growth rate (CAGR) of 12.7%, reaching $401.4 billion by 2029. This…
Propranolol Reduces Tremors in Parkinson’s Disease: Insights into the Role of Stress and the Brain Parkinson’s disease is a progressive neurodegenerative disorder that affects movement, often leading to symptoms such…
WuXi AppTec Recognized for Its Continued Commitment to Environmental, Social, and Governance Excellence WuXi Biologics a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has proudly announced its inclusion…
The “Precision Medicine Software Market: Focused Insights 2024-2029” explores the dynamics Genomics of a rapidly growing industry. Valued at USD 1.72 billion in 2023, the market is expected to grow…
OS Therapies Announces $6 Million Private Placement to Fund Clinical Development of OST-HER2 for Osteosarcoma and Other Cancer Indications OS Therapies, a clinical-stage biotechnology company focused on developing innovative cancer…